ADVERSE DRUG REACTION;
B CELL LYMPHOMA;
DRUG THERAPY;
HEART TRANSPLANTATION;
HUMAN;
HUMAN CELL;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
Cyclosporine A initially as the only immunosuppressant in 34 recipients of cadaveric organs
Calne RY, Rolles K, White DJG, et al. Cyclosporine A initially as the only immunosuppressant in 34 recipients of cadaveric organs. Lancet 1979; 2: 1033
Results of cyclosporine to azathioprine conversion in cadaveric renal transplantation
Gonwa TA, Nghiem DD, Schulak JA, et al. Results of cyclosporine to azathioprine conversion in cadaveric renal transplantation. Transplantation 1987; 43: 225
A randomized trial comparing triple-drug and double-drug therapy in renal transplantation
Ponticelli C, Tarantino A, Montagnino G, et al. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation. Transplantation 1988; 45: 913
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children
Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719